Brought to you by 
Magen BioSciences gets $15.4mm with its Series A round
21 Sep 2006
Executive Summary
Magen BioSciences (dermatology treatments) has closed its $15.4mm Series A venture round. Highland Capital led the financing and was joined by new backers IDG Ventures and QVT Financial and current shareholders Alexandria Real Estate, Arch Venture Partners, Lux Capital, TVM Capital, and Venrock Associates.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Magen BioSciences gets $15.4mm with its Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice